zotatifin
effector therapeutics
['eft226', 'zotatifin', 'effector therapeutics', '$eftr']
$eftr [15s. delayed]: issued press release on june 05, 17:00:00: effector therapeutics reports positive interim results in zotatifin (eft226) phase 1/2 clinical trial at asco 2022 showing safety and tolerability, and initial signals of clinical activity 
Flash Alert is a low-latency financial news service which sources SEC, press releases, credible news sources to get your news about stocks in near real-time